MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS

Erica H. Bell; Peixin Zhang; Edward G. Shaw; Jan C. Buckner; Geoffrey R Barger; Stephen W. Coons; Dennis E. Bullard; Minesh P. Mehta; Mark R. Gilbert; Paul D. Brown; Keith J. Stelzer; Joseph P. McElroy; Jessica Fleming; Arup Chakraborty; Aline Paixao Becker; Kenneth D. Aldape; David G. Brachman; Albert D. Murtha; Christopher J Schultz; David Johnson; Stanley Z Gertler; Nadia N. Laack; Maria Werner-Wasik; Ian R. Crocker; Arnab Chakravarti

doi:10.1093/neuonc/now212.444

MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS

Erica H. Bell
, Peixin Zhang
, Edward G. Shaw
, Jan C. Buckner
, Geoffrey R Barger
, Stephen W. Coons
, Dennis E. Bullard
, Minesh P. Mehta
, Mark R. Gilbert
, Paul D. Brown
, Keith J. Stelzer
, Joseph P. McElroy
, Jessica Fleming
, Arup Chakraborty
, Aline Paixao Becker
, Kenneth D. Aldape
, David G. Brachman
, Albert D. Murtha
, Christopher J Schultz
, David Johnson

Stanley Z Gertler, Nadia N. Laack, Maria Werner-Wasik, Ian R. Crocker, Arnab Chakravarti

Herbert Wertheim Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	18
DOIs	https://doi.org/10.1093/neuonc/now212.444
State	Published - Nov 1 2016

Disciplines

Pathology
Critical Care
Other Medical Specialties

Access to Document

10.1093/neuonc/now212.444License: Unspecified

Cite this

Bell, E. H., Zhang, P., Shaw, E. G., Buckner, J. C., Barger, G. R., Coons, S. W., Bullard, D. E., Mehta, M. P., Gilbert, M. R., Brown, P. D., Stelzer, K. J., McElroy, J. P., Fleming, J., Chakraborty, A., Becker, A. P., Aldape, K. D., Brachman, D. G., Murtha, A. D., Schultz, C. J., ... Chakravarti, A. (2016). MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS. Neuro-oncology, 18. https://doi.org/10.1093/neuonc/now212.444

Bell, EH, Zhang, P, Shaw, EG, Buckner, JC, Barger, GR, Coons, SW, Bullard, DE, Mehta, MP, Gilbert, MR, Brown, PD, Stelzer, KJ, McElroy, JP, Fleming, J, Chakraborty, A, Becker, AP, Aldape, KD, Brachman, DG, Murtha, AD, Schultz, CJ, Johnson, D, Gertler, SZ, Laack, NN, Werner-Wasik, M, Crocker, IR & Chakravarti, A 2016, 'MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS', Neuro-oncology, vol. 18. https://doi.org/10.1093/neuonc/now212.444

@article{2283ff35860e410bbb624b6758721582,

title = "MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS",

author = "Bell, \{Erica H.\} and Peixin Zhang and Shaw, \{Edward G.\} and Buckner, \{Jan C.\} and Barger, \{Geoffrey R\} and Coons, \{Stephen W.\} and Bullard, \{Dennis E.\} and Mehta, \{Minesh P.\} and Gilbert, \{Mark R.\} and Brown, \{Paul D.\} and Stelzer, \{Keith J.\} and McElroy, \{Joseph P.\} and Jessica Fleming and Arup Chakraborty and Becker, \{Aline Paixao\} and Aldape, \{Kenneth D.\} and Brachman, \{David G.\} and Murtha, \{Albert D.\} and Schultz, \{Christopher J\} and David Johnson and Gertler, \{Stanley Z\} and Laack, \{Nadia N.\} and Maria Werner-Wasik and Crocker, \{Ian R.\} and Arnab Chakravarti",

note = "BACKGROUND:This study sought to determine the proportion of patients with 1p/19q co-deletion and its prognostic significance in the setting of NRG Oncology/RTOG 9802, a phase III trial of high-risk low-grade gliomas.METHODS:Oncoscan and/or 450K methylation data were used to determine 1p/19q status. Univariable (UVAs) and multivariable analyses (MVAs) were performed using the Cox proportional hazard model.",

year = "2016",

month = nov,

day = "1",

doi = "10.1093/neuonc/now212.444",

language = "American English",

volume = "18",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS

AU - Bell, Erica H.

AU - Zhang, Peixin

AU - Shaw, Edward G.

AU - Buckner, Jan C.

AU - Barger, Geoffrey R

AU - Coons, Stephen W.

AU - Bullard, Dennis E.

AU - Mehta, Minesh P.

AU - Gilbert, Mark R.

AU - Brown, Paul D.

AU - Stelzer, Keith J.

AU - McElroy, Joseph P.

AU - Fleming, Jessica

AU - Chakraborty, Arup

AU - Becker, Aline Paixao

AU - Aldape, Kenneth D.

AU - Brachman, David G.

AU - Murtha, Albert D.

AU - Schultz, Christopher J

AU - Johnson, David

AU - Gertler, Stanley Z

AU - Laack, Nadia N.

AU - Werner-Wasik, Maria

AU - Crocker, Ian R.

AU - Chakravarti, Arnab

N1 - BACKGROUND:This study sought to determine the proportion of patients with 1p/19q co-deletion and its prognostic significance in the setting of NRG Oncology/RTOG 9802, a phase III trial of high-risk low-grade gliomas.METHODS:Oncoscan and/or 450K methylation data were used to determine 1p/19q status. Univariable (UVAs) and multivariable analyses (MVAs) were performed using the Cox proportional hazard model.

PY - 2016/11/1

Y1 - 2016/11/1

UR - https://academic.oup.com/neuro-oncology/article/2542681/MPTH-06.

U2 - 10.1093/neuonc/now212.444

DO - 10.1093/neuonc/now212.444

M3 - Article

VL - 18

JO - Neuro-oncology

JF - Neuro-oncology

ER -

MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS

Disciplines

Access to Document

Other files and links

Cite this